INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / BIOTECHNOLOGY
Symbol
PBE
Price per share
$82.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
978,161
Total reported value
$68,443,763
% of total 13F portfolios
0%
Share change
-297,423
Value change
-$20,741,981
Number of holders
98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 98 institutional investors reported holding 978,161 shares of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE).

Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 11,575 $959,630 +$21,434 $82.15 4
2025 Q3 978,161 $68,443,763 -$20,741,981 $69.87 98
2025 Q2 1,279,367 $82,042,365 -$2,862,018 $64.10 95
2025 Q1 1,323,152 $83,927,905 -$175,979 $63.44 95
2024 Q4 1,326,022 $88,260,503 +$867,793 $66.53 97
2024 Q3 1,322,938 $92,410,456 -$7,574,963 $69.82 103
2024 Q2 1,423,568 $92,271,001 +$14,972,145 $64.81 100
2024 Q1 1,201,145 $77,685,792 -$13,859,542 $64.72 101
2023 Q4 1,200,100 $79,018,098 +$7,608,470 $65.84 95
2023 Q3 1,295,402 $73,895,313 -$283,849 $57.04 96
2023 Q2 1,302,175 $79,837,312 +$58,835 $61.29 97
2023 Q1 1,291,721 $81,080,858 +$5,184,618 $62.77 101
2022 Q4 1,212,633 $77,018,370 +$6,484,805 $63.50 103
2022 Q3 1,105,133 $65,142,145 -$3,370,422 $58.94 85
2022 Q2 1,091,048 $63,008,282 +$10,620,634 $57.74 85
2022 Q1 910,188 $56,421,786 -$8,928,314 $62.01 86
2021 Q4 1,082,157 $77,062,024 +$6,820,182 $71.21 99
2021 Q3 973,841 $72,916,745 +$4,475,875 $74.85 96
2021 Q2 908,416 $70,221,116 +$1,401,390 $77.33 93
2021 Q1 890,865 $64,249,163 +$102,795 $73.82 87
2020 Q4 862,753 $60,558,549 -$3,846,633 $70.13 79
2020 Q3 924,537 $52,457,488 +$730,117 $56.62 70
2020 Q2 909,544 $53,049,217 -$1,578,571 $58.27 74
2020 Q1 975,538 $45,554,572 -$4,876,335 $46.50 72
2019 Q4 1,102,338 $61,422,888 -$7,787,450 $55.85 75
2019 Q3 1,206,844 $57,132,948 -$1,297,503 $47.37 70
2019 Q2 1,235,172 $66,066,408 -$12,704,520 $53.51 76
2019 Q1 1,463,426 $80,670,762 -$5,591,400 $55.18 76
2018 Q4 1,604,631 $75,704,298 +$1,970,607 $47.07 69
2018 Q3 1,568,125 $93,163,101 +$35,721,803 $59.45 69
2018 Q2 917,622 $50,276,665 +$50,276,668 $54.71 67
2016 Q1 1,603 $90,000 $0 $56.14 1